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Cells extracts from Thermus thermophilusHB27 express phosphorolytic activities on purines and pyrimidine nucleosides. Five
putative encoding genes were cloned and expressed in Escherichia coli, and the corresponding recombinant proteins were puri-
fied and studied. Two of these showed phosphorolytic activities against purine nucleosides, and third one showed phosphoro-
lytic activity against pyrimidine nucleosides in vitro, and the three were named TtPNPI, TtPNPII, and TtPyNP, respectively. The
optimal temperature for the activity of the three enzymes was beyond the water boiling point and could not be measured accu-
rately, whereas all of them exhibited a wide plateau of optimal pHs that ranged from 5.0 to 7.0. Analytical ultracentrifugation
experiments revealed that TtPNPI was a homohexamer, TtPNPII was a monomer, and TtPyNP was a homodimer. Kinetic con-
stants were determined for the phosphorolysis of the natural substrates of each enzyme. Reaction tests with nucleoside ana-
logues revealed critical positions in the nucleoside for its recognition. Activities with synthetic nucleobase analogues, such as
5-iodouracil or 2,6-diaminopurine, and arabinosides were detected, supporting that these enzymes could be applied for the syn-
thesis of new nucleoside analogs with pharmacological activities.
Nucleoside phosphorylases (NPs) constitute a family of ubiq-uitous enzymes involved in the salvage pathway of nucleo-
sides in prokaryotic and eukaryotic organisms, in which they cat-
alyze the reversible phosphorolysis of nucleosides (Fig. 1A). They
are generally classified attending to their substrate specificity as
purine NPs (PNPs; EC 2.4.2.1) or pyrimidine NPs (PyNPs; EC
2.4.2.2). Other classifications regarding their molecular mass and
structure have also beenmade (4), although several NPs have been
reported to deviate from these proposed classes (6–8, 14). It is not
possible to establish a clear relationship between a given sequence
or structure and its nucleoside specificity.
Human NPs are therapeutic targets in tumoral cells, where
they are overproduced. Treatment of these types of cancer involve
strategies, such as the design of inhibitors of human NPs that
hinder the ability of tumoral cells to replicate their DNA by lim-
iting the available pool of nucleotides, and the administration of
nucleobase analogues, which are innocuous when conjugated
with a pentose but cytotoxic once phosphorolyzed by an NP (20,
21, 29). Aside from these applications, there are a number of other
examples of the use of nucleoside analogues with antirheumatic,
antiviral, or antimicrobial properties (27, 34).
The synthesis of nucleoside analogues can be achieved by either
chemical or enzymatic methods or by a combination of both (33).
The enzymatic methods have several advantages, such as a high
regio- and stereoselectivity, mild reaction conditions, and limited
use of contaminant reagents and organic solvents. NPs are one of
themost widely spread tools for the synthesis of these compounds
since they catalyze the specific combination of nucleobases and
sugars (5, 17, 22).
To date, NPs fromdifferentmesophiles, such as Escherichia coli
(15–16, 31) or Bacillus subtilis (5), have been used in the synthesis
of pharmacologically active compounds (16, 31). However,meso-
philic enzymes exhibit a limited ability to withstand aggressive
conditions with respect to pH, organic solvents, or elevated tem-
peratures, which are frequently required to reduce the viscosity of
the medium or to increase the solubility and concentration of
some substrates (32). In these cases, enzymes from thermophilic
microorganisms (or thermozymes) are ideal substitutes formeso-
philic enzymes. The adaptive features found in thermozymes,
such as a highly polar surface, a more compact hydrophobic core,
and a reduced number of cavities and external loops, correlate not
only with an increased thermostability but also with a wider tol-
erance to other stresses, such as low pH, organic solvents, and
denaturing agents. Another important side effect of their natural
thermostability of interest in an industrial process is that many of
themare easily purified from the soluble fraction after a heat shock
treatment that denatures most of the host proteins of the meso-
philic host where they are overproduced. To date, thermophilic
NPs from themoderate thermophileGeobacillus stearothermophi-
lus are the only examples that have been applied in the synthesis of
nucleosides (11, 30).
We reported previously the existence of nucleoside synthase
activities in the whole cells of several T. thermophilus strains, in-
cluding the sequenced strain HB27 (2). Here, we search for the
genes encoding these activities in the genome of T. thermophilus
HB27 (9) and identify three NP activities with a complementary
set of specificities for substrates. We show that these enzymes are
active in the synthesis of both natural and synthetic nucleosides at
high temperatures.
MATERIALS AND METHODS
Strains and culture media. T. thermophilusHB27 was used as a source of
genes encoding putative NPs (9). The cells were cultured in TB medium
(0.8% [wt/vol] peptone, 0.4% [wt/vol] yeast extract, 0.3% [wt/vol] NaCl
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[pH 7.5]) at 65°C with stirring (150 rpm). E. coli strains DH5 [supE44
(lacZYA-argF)U169 (80dlacZM15) hsdR17 recA1 endA1 gyrA96 thiI
relA1] and BL21(DE3) [hsdS gal(cIts857 ind-1 Sam7 nin-5 lacUV5-T7
gene 1)] were used for gene cloning and protein expression, respectively.
Both strainswere grownonLuria-Bertanimedium (1%[wt/vol] tryptone,
0.5% [wt/vol] yeast extract, 0.5% [wt/vol] NaCl [pH 7.0]) at 37°C with
stirring (150 rpm).
Identification of genes encoding putative NPs. The genome of T.
thermophilus HB27 was examined for putative NPs using the KEGG
server. Two putative PNPs with the T. thermophilus HB27 locus IDs
TTC0194 (UniProt Q72L69) and TTC1070 (UniProt Q72IR2) and a pu-
tative thymidine phosphorylase with the locus ID TTC1412 (UniProt
Q72HS4) were identified. In addition, a search for paralogues highlighted
11 additional genes, whose products were analyzed by multiple sequence
alignments and domain identification. Three of them—loci TTC0188
(UniProt Q72L73), TTC1185 (UniProt Q72IE7), and TTC1491 (UniProt
Q72HJ6)—had NP-like domains and were selected for cloning.
Cloning, expression, and purification of NPs. The selected genes
were amplified by PCR using the oligonucleotides described in Table 1. In
all cases, NdeI and EcoRI restriction sites were included in the forward
and reverse primers, respectively. The PCR products were subcloned into
pGEM-T and transferred to pET22b. In the resulting expression vectors,
the genes were transcribed under the control of a promoter dependent on
the T7 phage RNA polymerase. Protein expression was assessed in E. coli
BL21(DE3) cells by the addition of 1 mM IPTG (isopropyl--D-thioga-
lactopyranoside) to exponential-phase cultures (optical density at 600 nm
[OD600] of 0.3 to 0.4) growing at 37°C. The cells were harvested by cen-
trifugation when they reached anOD600 of 1, washed with 50mM sodium
phosphate buffer (pH 7.0), resuspended in a 1/100 volume of the same
buffer, and subjected to sonication (five pulses of 15 s at maximum am-
plitude; Labsonic M). The crude cell extracts were heated at 80°C for 1 h,
and the supernatant containing the produced protein was cleared by ul-
tracentrifugation. The enzyme purity was checked by SDS-PAGE. For
analytical ultracentrifugation experiments, the heat-purified extracts
were bound to a 1-ml Mini-Macro-Prep High-Q column mounted in a
BioLogic LP system (Bio-Rad), equilibrated in the same buffer (50 mM
sodium phosphate buffer [pH 7.0]), and eluted with a constant 0 to 0.5M
NaCl gradient. Fractions containing the protein were pooled, desalted,
and concentrated using an Amicon Ultra-15 centrifugal filter unit (Milli-
pore). The concentrate was then bound to a 1-ml Mini-Macro-Prep
High-S column and eluted with a 0 to 0.5 M NaCl gradient. Protein-
containing fractionswere pooled, desalted, and concentrated. The protein
concentration was measured by the BCA method with the protein assay
kit from Bio-Rad.
NP assays. Analysis of nucleoside phosphorolysis was performed us-
ing 5 mM nucleoside in 50 mM sodium phosphate buffer (pH 7.0) and 5
g of enzymatic extract ml1. The reaction was performed at 65°C for 30
min and stopped by the addition of 1 volume of ice-cold methanol. The
one-pot synthesis of nucleosides was performed by a coupled enzymatic
reaction (Fig. 1B). Standard conditions for the synthetic reactions were as
follows: 2.5 mM acceptor nucleobase and 5 mM nucleoside donor in 50
mM sodium phosphate buffer (pH 7.0), 10 g of NP1 enzymatic extract
ml1 (when added), and 5 g of NP2 enzymatic extract ml1. The reac-
tion was developed at 65°C for 30 min and stopped by the addition of 1
volume of ice-cold methanol. The abbreviations used for the nucleosides
and bases are as follows: 5-FC, 5-fluorocytosine; 5-IU, 5-iodouracil;
6-tFMeU, 5-trifluoromethyluracil; A, adenine; ACV, acyclovir; Ado,
adenosine; ara-A: adenine-arabinoside; ara-U, uracil-arabinoside; AZT,
azidothymidine; BI, benzimidazole; C, cytosine; Ctd, cytidine; dAdo, 2=-
deoxyadenosine;DAP, 2,6-diaminopurine; dCtd, 2=-deoxycytidine;DFU,
2-deoxy-2-fluorouracil; dGuo, 2=-deoxyguanosine; dIno, 2=-deoxyino-
sine; dUrd, 2=-deoxyuridine; FMPy, 5-fluoro-2-methoxy-4(1H)-pyrim-
idinone; G, guanine; Guo, guanosine; HX, hypoxanthine; Ino, inosine; T,
thymine; Thd, thymidine; U, uracil; and Urd, uridine.
Analysis of the reaction products. After reaction, the samples were
analyzed immediately using high-pressure liquid chromatography (Agi-
lent Series 1100) equipped with a Mediterranean Sea C18 column (15 by
0.46 cm, 5-mparticle size; Teknokroma) equipped with an UV detector
FIG 1 Scheme of the reaction catalyzed by nucleoside phosphorylases. (A) Phosphorolytic and the synthetic pathways. (B) Synthesis of nucleosides by coupled
NP activity reactions. A donor nucleoside is cleaved by an NP, yielding a free nucleobase (B1) and a pentose-1-P. The pentose is then used in a new reaction by
either the same or a different NP, along with an acceptor nucleobase (B2) to synthesize a new nucleoside.
TABLE 1 Oligonucleotides used in this study
Primer Sequence (5=–3=)a
TTC0188F TTCCATATGGTGTGGCTCCTCCTTTCCCCCA
TTC0188R TTCGAATTCTCAGCCGGGGGGCCTACG
TTC0194F TTCCATATGATGCCGGATATGGAGCTC
TTC0194R TTCGAATTCTCAGAGCTCGGCGAGGAT
TTC1185F TTCCATATGGTGACCGCCTTCTTCGCCGCCGA
TTC1185R TTCGAATTCTCACTCTACCAGGGCCCGGGCGA
TTC1070F TTCCATATGATGAGCCCCATCCACGTG
TTC1070R TTCGAATTCTCAAACCTCCAGGACGGC
TTC1412F TTCCATATGATGAACCCCGTGGTCTTCATCCGGGA
TTC1412R TTCGAATTCCTAGATGGCCTCCAGGACCAAGGG
TTC1491F TTCCATATGATGGACGCGGTGAAGAAGGCCA
TTC1491R TTCGAATTCCTAGGCCCTGAGAAAGGCCACG
a Restriction sites for NdeI (CATATG) and EcoRI (GAATTC) are indicated in italics,
and the nucleotide excess sequences for proper anchoring of the restriction enzymes are
underlined.
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set at 254 nm andH2O-CH3OH (95:5) as the mobile phase. For the phos-
phorolytic reactions, the disappearance of the nucleoside and appearance
of the nucleobase was monitored. For the synthetic reactions, the disap-
pearance of the acceptor nucleobase and the appearance of the new nu-
cleoside were monitored.
Analytical ultracentrifugation. The analytical centrifugation experi-
ments were carried with an Optima XL-I (Beckman-Coulter, Inc.) ultra-
centrifuge equipped with UV absorbance optics, an An-50Ti rotor, and
1.2-cm double-sector center pieces of Epon-charcoal. Protein samples
were analyzed at 20°C in 50 mM sodium phosphate buffer (pH 7.0). For
sedimentation velocity experiments, the software SEDFIT (25) was used
to calculate the sedimentation coefficient (S), and the apparent sedimen-
tation coefficient of distribution [c(s)] from the experimental data. For
sedimentation equilibrium experiments, the calculated buoyant molar
mass (Mb) values were converted into molar mass (M) values according
to the formula: MbM(1 vr), where v is the partial specific volume of
the protein (calculated from the amino acid sequence), and r is the buffer
density. The HeteroAnalysis software developed by James L. Cole (http:
//www.biotech.uconn.edu/auf/) was used for these analyses.
RESULTS
Cloning, expression, and purification. TTC0188, TTC0194,
TTC1070, TTC1412 and TTC1941 were successfully cloned and
expressed in theE. coliBL21(DE3)/pET22b system.All attempts to
express TTC1185 were unsuccessful. Induced cell extracts showed
overproduced proteins of the expected size, although the amount
produced was different in each case (Fig. 2, lanes 1), with the
lowest production levels detected for TTC0188. After heat treat-
ment, ca. 10 to 12% of the total proteins remained in the soluble
fraction in the production of TTC0194, TTC1070, and TTC1412,
whereas only a 3 to 4% of the total proteins remained soluble in
the case of TTC0188 andTTC1491. The purity of the thermostable
proteins in the heat-purified fractions was estimated to be ca. 40%
by densitometry analysis of Coomassie blue-stained PAGE gels.
For enzymatic assays, this value was deemed acceptable, since the
amount of NPs recovered was enough to detect activity, and none
of the background proteins from the host organism interfered in
the assays. Purification by ion-exchange chromatography of
TTC0194, TTC1070, and TTC1412 heat-purified extracts yielded
purities close to 95%, as analyzed by gel staining.
Detection of NP activity. The heat-purified recombinant en-
zymes were tested against a set of natural nucleosides in order to
detect phosphorolysis. Adenosine (Ado), 2=-deoxyadenosine
(dAdo), inosine (Ino), 2=-deoxyinosine (dIno), guanosine (Guo),
2=-deoxyguanosine (dGuo), uridine (Urd), 2=-deoxyuridine
(dUrd), thymidine (Thd), cytidine (Cyt), and 2=-deoxycitidine
(dCyt) were used in this initial test. The results are summarized in
Table 2.
Although sequence analysis and domain prediction identi-
fied UDP_PNP_1 domains within TTC0188 and TTC1941,
none of them showed phosphorolytic activity against any nu-
cleoside, and so they were consequently rejected from further
assays. In contrast, TTC1070 and TTC0194 showed specificities
typical of purine NP, where TTC1070 was specific for 6-oxo-
purine (2=-deoxy)ribosides (hypoxanthine and guanine), and
TTC0194 was specific for 6-aminopurine (2=-deoxy)ribosides
(adenine). According to the classification of NPs proposed by
Pugmire and Ealick (24), these enzymes would be included in
the type I category. A third protein, TTC1412, showed speci-
ficity for uracil and thymine (2=-deoxy)ribosides, but not for
cytosine. According to the same classification, TTC1412 would
be included in the type II category. However, the specificity of
this enzyme does not correlate with classical uridine phosphor-
ylases (UP) or thymidine phosphorylases (TP) but to a class of
pyrimidine NP (PyNP) found in bacteria such as Haemophilus
influenzae (26) and Geobacillus stearothermophilus (19) that
do not discriminate between these bases and the presence or
absence of a hydroxyl group at the 2= position of the ribose
moiety.
It is interesting that the three enzymes favored the use of 2=-
deoxyribosides rather than ribosides and that their specificity did
not overlap, covering almost every combination of nucleobase
and sugar, in agreementwith our previous findings on cell extracts
from this strain (2). Due to these results, we renamed TTC1070,
TTC0194, and TTC1412 as TtPNPI, TtPNPII, and TtPyNP, re-
spectively.
Analytical ultracentrifugation. Sedimentation velocity and
sedimentation equilibrium experiments were performed on puri-
FIG 2 Purification of proteins TTC0188, TTC1491, TTC0194, TTC1070, and TTC1412. The indicated proteins were overproduced from the corresponding
pET22bderivatives inE. coliBL21 cells. Lanes: 1, whole extract obtained after cell disruption by sonication; 2, soluble fraction after incubation of thewhole extract
at 80°C for 1 h; 3, purification by ion-exchange chromatography of the heat-treated extract; M, size markers (in kilodaltons).
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fied TtPNPI, TtPNPII, and TtPyNP. Sedimentation velocity ex-
periments showed that a single species was present in samples of
the purified proteins (Fig. 3). Sedimentation equilibrium experi-
ments were performed to obtain their molar masses. After correc-
tion of the buoyantmolarmasses, themolecularmasses calculated
for the proteins were 156 1 kDa, 30 0 kDa, and 73 1 kDa for
TtPNPI, TtPNPII, and TtPyNP, respectively. Taking into account
the theoretical mass deduced from the amino acid sequence of
each protein (25, 30, and 45 kDa, in the same order) it was con-
cluded that TtPNPI forms hexamers, TtPNPII monomers, and
TtPyNP dimers.
Phosphorolysis of nucleosides. The ability of the three pro-
teins to phosphorolyze natural and synthetic nucleosides was ex-
plored. The three enzymes showed high sensitivity to modifica-
tions in the sugar moiety. TtPNPI was unable to phosphorolyze
acyclovir (ACV) (Table 3), which could be attributed to the pres-
ence of an open analogue of ribose rather than to the conjugated
guanine, since activity against guanosine and 2=-deoxyguanosine
was detected (Table 2). The activities of TtPNPII and TtPyNP
against nucleosides carrying an arabinose moiety were dramati-
cally lower than those carrying the natural isomer 2=-deoxyribose,
as illustrated by the difference in phosphorolysis between 2=-de-
oxyadenosine (34%) and adenine-arabinoside (ara-A) (1%) or
between 2=-deoxyuridine (55%) and uracil-arabinoside (ara-U)
(3%) (Table 3). In addition, the lack of phosphorolytic activity of
TtPyNP against AZT (Table 3), which carries substituents in
positions 3= and 5=, suggests a dependence of the activity for an
adequate fitting of the pentose into the active site of the enzyme.
Synthesis of nucleosides.One of the most important features
of the NP-catalyzed reaction is its reversible character, which al-
lows it to not only phosphorolyze a nucleoside but also to synthe-
size a new one by combining an acceptor nucleobase and a pen-
tose-1P. The ability of TtPNPI, TtPNPII, and TtPyNP to perform
synthesis of new nucleosides was explored with different base ac-
ceptors and 2=-deoxyribose-1P. However, since 2=-deoxyri-
bose-1P is not commercially available, the synthetic reaction was
coupled to the phosphorolysis of a 2=-deoxynucleoside, which
yields 2=-deoxyribose-1P (Fig. 1B). The phosphorolysis of either
Thd or dUrd by TtPyNP was chosen for this end, since these sub-
strates showed the highest phosphorolytic activities (Table 2). The
results of the synthesis assays, as well as a schematic view of the
TABLE 2 Phosphorolytic activity of recombinant enzymes on natural nucleosidesa
Substrate
Mean phosphorolytic activity (%) SD
TTC0188 TTC0194 TTC1070 TTC1412 TTC1491
Adenosine ND 24.2 0.2 ND ND ND
2=-Deoxyadenosine ND 27.8 0.4 ND ND ND
Guanosine ND ND 8.7 0.1 ND ND
2=-Deoxyguanosine ND ND 22.5 0.3 ND ND
Inosine ND ND 19.1 0.2 ND ND
2=-Deoxyinosine ND ND 40.5 0.3 ND ND
Uridine ND ND ND 15.2 0.5 ND
2=-Deoxyuridine ND ND ND 40.0 1.2 ND
Thymidine ND ND ND 29.7 0.9 ND
Cytidine ND ND ND ND ND
2=-Cytidine ND ND ND ND ND
a Reaction conditions: 5 mM nucleoside in sodium phosphate buffer (50 mM, pH 7.0), 5 g of enzyme extract ml1. Reactions were performed for 30 min at 65°C and stopped in 1
volume of ice-cold methanol. The activities are expressed as a percentage of phosphorolyzed nucleoside with respect to the total amount of nucleoside used as a substrate. ND, not
detected.
FIG 3 Determination of T. thermophilusHB27 NP oligomeric state by analyt-
ical ultracentrifugation. (A) TtPNPI, 0.35mg/ml in 50mM sodium phosphate
(pH 7.0) at 20°C, 50,000  g. (B) TtPNPII, 0.22 mg/ml in 50 mM sodium
phosphate (pH 7.0) at 20°C, 50,000  g. (C) TtPyNP, 0.53 mg/ml in 50 mM
sodium phosphate (pH 7.0) at 20°C, 50,000 g.
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experimental setup, are depicted in Table 4. TtPNPI was able to
synthesize 6-oxopurine nucleosides, in agreement with the speci-
ficities previously observed against (2=-deoxy)guanosine and (2=-
deoxy)inosine (Table 2). However, it was unable to synthesize
nucleosides when the acceptor lacked substituents for its recogni-
tion (benzimidazole [BI]) or contained a 6-amino group (2,6-
diaminopurine [DAP]). In contrast, TtPNPII synthesized amino-
purine nucleosides, showing similar yields with adenine and DAP
(49.1 and 41.7%, respectively). Thus, the presence of a substituent
in position 2 of the purine ring was not required for ligand recog-
nition by this enzyme, for which the fitting of position 2-substi-
tuted adenines in the catalytic pocket may be limited by steric
hindrance. However, the presence of a 6-amino group in the pu-
rine ring proved to be essential for the ligand recognition by
TtPNPII, as shown by the lack of synthetic activity when BI was
used as acceptor.
TtPyNP was also able to carry out the synthesis of nucleosides
when the pyrimidine acceptor was 2,4-dioxo substituted, and the
reaction did not proceed when either one (5-fluorocytosine [5-
FC]) or both substituents (2-deoxy-2-fluorouracil [DFU] and
5-fluoro-2-methoxy-4(1H)pyrimidinone [FMPy]) were absent.
This dependence on the 2,4-dioxo groups could be explained on
the basis of the specificities for phosphorolysis observed, where
TtPyNPwas able to cleave uracil and thymine nucleosides, but not
cytosine nucleosides, which are 2-oxo,4-amino substituted (Table
2). Substituents in the pyrimidine ring prevented the synthesis
reaction when located in the 6-carbon, as revealed by the lack of
activity against FMPy, but substitutions in position 5, such as with
5-IU, were tolerated by the enzyme. This flexibility in position 5
would explain the ability of the enzyme to recognize both uracil
and 5-methyluracil (thymine).
Optimization of reaction conditions. The experimental con-
ditions for the phosphorolytic activity of the NPs were optimized.
The phosphate buffer concentrationwas fixed at 50mM, although
higher concentrations did not affect the activity of the enzymes,
except in the case of TtPyNP, which showed high sensitivity be-
yond 100 mM (Fig. 4A). Regarding the pH of the medium, the
three enzymes were widely tolerant, showing a pH plateau be-
tween 5.0 and 7.0, rather than an optimum (Fig. 4B).
As expected, the three enzymes were active at high tempera-
tures (Fig. 4C), to the extreme that conversion rates kept rising
beyond the water boiling point. Therefore, a compromise was
reached between high activity values and the convenience of the
experimental procedure, and 80°Cwas set as the standard temper-
ature for the assays. According to this activity at high tempera-
tures, the half-lives of TtPNPI and TtPNPII at 80°C were quite
long (132 and 232 h, respectively). However, TtPyNP was much
more heat sensitive, with a half-life of 2 h under the same condi-
tions (data not shown).
Synthesis of nucleoside analogues frequently uses organic
solvents when either the substrates and/or their products have
low solubility in aqueous medium.We assayed the ability of the
three enzymes to catalyze NP reactions in the presence of dif-
ferent concentrations (5 to 50% [vol/vol]) of dimethylforma-
mide (DMFA), dimethyl sulfoxide (DMSO), and 2-methyltet-
rahydrofuran (2-MeTHF). In order to correlate the effect of the
solvent to the enzymatic activity, nucleoside phosphorolysis
assays were performed as phosphorolytic reactions on 2=-de-
oxyinosine (TtPNPI), 2=-deoxyadenosine (TtPNPII), or 2=-de-
oxyuridine (TtPyNP). The heat-purified enzymes were added
at a concentration of 5 g ml1 to a reaction mixture contain-
TABLE 3 Phosphorolysis of nucleosides by T. thermophilus NPsa
Enzyme Nucleoside Nucleobase features Sugar moiety features Mean (%) phosphorolysis SDb
TtPNPI dIno 6-Oxo 2=-Deoxyribose 58.4 0.6
ACV 6-Oxo,2-amino Open ring ND
TtPNPII dAdo 6-Amino 2=-Deoxyribose 34.0 0.3
ara-A 6-Amino Arabinose 1.0 0.1
TtPyNP dUrd 2,4-Dioxo 2=-Deoxyribose 55.0 1.1
ara-U 2,4-Dioxo Arabinose 3.2 0.1
AZT 2,4-Dioxo,5-methyl 3=-Azido-5=-phosphoribose ND
a Reaction conditions: 2.5 mM nucleoside in sodium phosphate buffer (50 mM, pH 7.0), 5 g of enzyme extract ml1, and 30 min at 65°C. Acronyms: dIno, 2=-deoxyinosine; ACV,
acyclovir; dAdo, 2=-deoxyadenosine; ara-A, adenine-arabinoside; dUrd, 2=-deoxyuridine; ara-U, uracil-arabinoside; AZT, azidothymidine.
b Percentage of nucleobase liberated with respect to the total amount of nucleoside used as a substrate. ND, not detected.
TABLE 4 Synthesis of nucleosides by T. thermophilus NPsa
Enzyme Acceptor Feature
% Synthesis
(mean SD)b
TtPNPI HX 2,6-Dioxo 42.0 0.5
BI Backbone only ND
DAP 2,6-Diamino ND
TtPNPII A 6-Amino 51.0 0.4
BI Backbone only ND
DAP 2,6-Diamino 41.7 1.5
TtPyNP U 2,4-Dioxo 49.1 1.3
5-FC 2-Oxo,4-amino,5-fluoro ND
DFU 2,4-Difluoro ND
6-tFMeU 2,4-Dioxo,6-trifluoromethyl ND
FMPy 5-Fluoro,2-methoxy ND
5-IU 2,4-Dioxo,5-iodo 47.8 1.1
a The transferred sugar moiety was a 2=-deoxyribose obtained by phosphorolysis of
dUrd or Thd by TtPyNP. The reaction conditions for nucleoside synthesis by TtPNPI
and TtPNPII were as follows: 5 mM dUrd and 2.5 mM acceptor nucleobase in sodium
phosphate buffer (50 mM, pH 7.0), 10 g of TtPyNP ml1, 5 g of TtPNPI or TtPNPII
ml1, and 30 min at 65°C. The reaction conditions for nucleoside synthesis by TtPyNP
were as follows: 5 mM Thd and 2.5 mM acceptor in sodium phosphate buffer (50 mM,
pH 7.0), 5 g of TtPyNP ml1, and 30 min at 65°C. Acronyms: HX, hypoxanthine; BI,
benzimidazole; DAP, 2,6-diaminopurine; A, adenine; U, uracil; 5-FU, 5-fluorouracil;
DFU, 2-deoxy-2-fluorouracil; 6-tMeFU, 6-trifluoromethyluracil; FMPy, 5-fluoro-2-
methoxy-4(1H)pyrimidinone; 5-IU, 5-iodouracil.
b Percentage of free nucleobase converted into nucleoside with respect to the total
amount of nucleobase used as a substrate. ND, not detected.
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ing 5 mM substrate in 50 mM sodium phosphate buffer (pH
7.0) and the organic solvent in the desired concentration. After
30 min of incubation at 80°C, the percentages of activity de-
tected in the presence of 50% DMFA, DMSO, and 2-MeTHF
were, respectively, as follows: TtPNPI, 30, 25, and 25%; TtPN-
PII, 20, 15, and 62%; and TtPyNP, 34, 20, and 40%. Since these
polar nonaqueous solvents are used to solubilize the substrates
and products used by these enzymes, such resistance reinforce
their potential in industrial applications.
Kinetic parameters of the enzymes. The Km and kcat values
were determined for the phosphorolysis of different substrates at
80°C for the three enzymes using heat-purified extracts. The re-
sults are summarized in Table 5. In agreement with the NP test
assays (Table 2), the kcat/Km ratios were higher for 2=-deoxyribo-
sides than for their respective ribosides. TtPNPI showed a higher
specificity against 6-oxo,2-aminopurine (guanine) than versus
6-oxopurine (hypoxanthine), while in the case of TtPyNP, higher
kcat/Km values were obtained with uracil nucleosides than with
thymidine.Moreover, the activation energywith one substrate per
enzyme (dGuo for TtPNPI, dAdo for TtPNPII, and dUrd for
TtPyNP) was calculated between 60 and 90°C using the Arrhenius
plot. The calculated activation energies (45.8, 46.0, and 45.1 kJ
mol1, respectively) were very similar for the three enzymes, sug-
gesting shared catalytic mechanisms.
DISCUSSION
A screening for putative thermostable NPs identified six putative
genes encoding homologues to these enzymes. We attempted to
overproduce the corresponding proteins in E. coli, where the dif-
ferences in thermostability would allow us to get a high enrich-
ment degree by differential denaturation of the host proteins
through heating.
One of the proteins selected, TTC1185, could not be produced.
We cannot assess the reason for this failure, but we hypothesize
that folding interferences during translation or toxicity could be
responsible for it. In this sense, it is relevant to note that the de-
velopment of structural genomic programs reveals that ca. 20 to
40% of the open reading frames encoded by thermophiles cannot
be overproduced in E. coli (12). Two other genes (TTC0188 and
TTC1491) produced soluble proteins that could be purified but
did not show any detectable NP activity with the substrates as-
sayed. Further in silico analysis showed a high similarity of
TTC0188 to a futalosine hydrolase (EC 3.2.2.26). A homologue of
FIG 4 Optimization of reaction conditions, i.e., the phosphate buffer con-
centration (A), medium pH (B), and temperature (C) in phosphorolytic
reactions carried out by TtPNPI (), TtPNPII (Œ), and TtPyNP (). The
values on the y axis correspond to the residual activity, where 1 is the
activity under standard conditions (50 mM sodium phosphate buffer [pH
7.0], 65°C).
TABLE 5 Kinetic parameters of NPsa
Substrate
TtPNPI TtPNPII TtPyNP
Km (mM) kcat (s
1) kcat/Km Km (mM) kcat (s
1) kcat/Km Km (mM) kcat (s
1) kcat/Km
Guo 0.53 0.01 296 2 558.78
dGuo 1.01 0.03 830 6 822.53
Ino 2.08 0.02 173 2 83.20
dIno 2.06 0.02 627 6 304.33
Ado 0.32 0.02 440 3 1,376.47
dAdo 0.36 0.03 563 4 1,563.53
Urd 0.12 0.01 202 6 1,683.33
dUrd 0.36 0.3 562 17 1,561.11
Thd 0.42 0.02 400 12 952.38
a Calculated kinetic parameters of T. thermophilusHB27 NPs with different substrates at 80°C. Values are presented as means the standard deviations where applicable.
Acronyms: Guo, guanosine; dGuo, 2=-deoxyguanosine; Ino, inosine; dIno, 2=-deoxyinosine; Ado, adenosine; dAdo, 2=-deoxyadenosine; Urd, uridine; dUrd, 2=-deoxyuridine; Thd,
thymidine.
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this protein from T. thermophilusHB8 was confirmed to have this
activity that has been proposed to be involved in a novel pathway
for the synthesis of menaquinones. In this pathway, futalosine is
synthesized from chorismate and inosine (10). It is likely that the
use of inosine as a substrate requires the presence of a purine-
binding domain inTTC0188, leading tomistaking this enzyme for
an NP on the basis of sequence comparisons and domains pres-
ence. On the other hand, TTC1491 showed high similarity with
anthranilate phosphoribosyl transferases (EC 2.4.2.18) from sev-
eral thermophilic genera, including Thermus. This enzyme is in-
volved in the synthesis of aromatic amino acids by performing the
reversible phosphorolysis of N-(5-phospho-D-ribosyl) anthra-
nilate and does not have NP activity, although structural analyses
include them within the same family (13).
Three other proteins—TTC1070, TTC0194, and TTC1412—
are bona fideNPs, with specificities for 6-oxopurines, 6-aminopu-
rines, and 2,4-dioxopyrimidines, respectively; we renamed these
proteins as TtPNPI, TtPNPII, and TtPyNP. Our analysis shows
that TtPNPI could be classified as a high-molecular-mass PNP,
despite the fact that the strict 6-oxo specificity constitutes an ex-
ception with respect to other high-molecular-mass PNPs. The
hexameric structure of this enzyme is in agreement with the three-
dimensional structure of a PNP from T. thermophilus HB8, with
which it shares a sequence identity of 91% (28). In contrast, the
monomeric nature of TtPNPII was surprising. No other PNP has
yet been reported to be monomeric, and homologues, such as the
human PNP, with which it shares 46% of identity (1), are trimers.
We cannot rule out the possibility that this enzyme could form
trimers in vivo, but our data clearly show that it is functional as a
monomer in vitro.
Hexameric PNPs from most organisms accept both adenine
and guanine. However, there are species, such asG. stearothermo-
philus, in which the activity is split between two different PNPs
with nonoverlapping specificities. This also seems to be the case
for T. thermophilus HB27, with a high-molecular-mass PNP
(TtPNPI) specific for 6-oxopurines (guanine and hypoxanthine)
and a low-molecular mass PNP (TtPNPII) specific for 6-amino-
purines (adenine). The relevance of these split activities is not
clear, but it could be related to the higher requirements for more
efficient repair systems at high temperatures.
In contrast to the separation of the activities on purines,
TtPyNP uses thymine as well as uracil as substrates. This broad
specificity is shared among PyNPs from organisms such as G.
stearothermophilus (19) andHaemophilus influenzae (26), as is the
fact that neither accepts cytosine nucleosides as a substrate. PyNPs
are usually divided into three categories: uridine phosphorylases
(UP), thymidine phosphorylases (TPs), and general-purpose
PyNPs, which accept both uracil and thymine nucleosides.
Whereas UPs are generally hexamers (and can also be classified as
PNPs), TPs and PyNPs are homodimers. In this sense, TtPyNP
follows this rule, showing the same quaternary structure with the
PyNP from G. stearothermophilus (23).
The chemical structure of the sugar moiety is fundamental for
substrate recognition, being ribose and 2=-deoxyribose recog-
nized, but not arabinose (ara-A or ara-U), 3-azido-5-phosphori-
bose (AZT), or open chains (acyclovir). Interestingly, the three
NPs are more prone to cleave 2=-deoxyribosyl nucleosides than
the corresponding ribonucleosides. This behavior is in contrast to
that described for mesophilic NPs (24) and could have evolved to
get nutrients from free DNA produced by accidental access of
mesophiles to the thermophilic environments inwhichT. thermo-
philus lives. Actually, T. thermophilus HB27 expresses constitu-
tively an exceptionally efficient natural competence apparatus
that allows the internalization of external DNA at huge rates (40
kb s1 cell1) (3). Internalized DNA is degraded into nucleosides
and phosphorolyzed by NPs, yielding 2=-deoxyribose-1P and the
corresponding base. These can either be used for synthesis or de-
graded to conserve energy. This way, T. thermophilus could sur-
vive and grow in an otherwise nutrient-poor environment.
These three enzymes were active in a broad temperature range,
even at temperatures bordering the water boiling point, although
TtPyNP lost half of the activity after 2 h at 80°C. This relatively low
thermostability could be related with the lability of the interaction
between monomers of this dimeric enzyme, which would also
explain the sensitivity to high ionic strength (Fig. 4A). Alterna-
tively, it could be the consequence of imperfect folding during its
synthesis in E. coli. This relatively low thermostability does not
seem to be shared by TtPNPI and TtPNPII, which remain active
after 5.5 and 9.6 days at 80°C, respectively. In this case, it seems
that the hexameric TtPNPI does not disassemble under these con-
ditions.
The characterization of these thermostable NPs from the ther-
mophile T. thermophilus is of great interest in the field of bioca-
talysis, since their broad specificity against natural substrates, as
well as their ability to use analogue substrates, permits the synthe-
sis of a new range of analogues by combining one or more en-
zymes with different substrates. The ability of TtPNPII to accept
position 2-modified adenines and of TtPyNP to accept position
5-substituted pyrimidines is especially interesting, since these are
positions commonly substituted in drugs used for the treatment
of human diseases. In this respect, the synthesis of 5-IU nucleo-
sides (Table 4) could prove to be an excellent property, since this
compound is an inhibitor of cancermetastasis (18).Moreover, the
thermophilic origin of these enzymes has some notable associated
advantages, such as an easy purificationmethodwith high protein
recovery, tolerance to a wide range of pH that lessens the need to
finely regulate the pH of the reactor, and thermostability at high
temperatures. Also, the three enzymes showed a remarkable resis-
tance to aggressive organic solvents such as DMFA, DMSO, or
2-MeTHF, which are required in the synthesis of compoundswith
low water solubility. All of these features indicate that the NPs
characterized here would be reliable biocatalysts for the synthesis
of nucleoside analogues.
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